CCL28 Has Dual Roles in Mucosal Immunity as a Chemokine with Broad-Spectrum Antimicrobial Activity 1
暂无分享,去创建一个
H. Ohtani | O. Yoshie | K. Hieshima | M. Shiota | T. Nakayama | M. Shibano | Takuya Saito | D. Izawa | F. Katou | Yuri Kawasaki | Fumio Shiba
[1] L. Kwak,et al. Mammalian defensins in immunity: more than just microbicidal. , 2002, Trends in immunology.
[2] A. Imberty,et al. Structural diversity of heparan sulfate binding domains in chemokines , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[4] Takaaki Ohtake,et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.
[5] H. Iwamoto,et al. Characterization of the metal-substituted dipeptidyl peptidase III (rat liver). , 2001, Biochemistry.
[6] J. Lieberman,et al. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. , 2001, The Journal of clinical investigation.
[7] M. Burdick,et al. Cutting Edge: IFN-Inducible ELR− CXC Chemokines Display Defensin-Like Antimicrobial Activity1 , 2001, The Journal of Immunology.
[8] J. Cyster,et al. A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell Movements , 2001, The Journal of experimental medicine.
[9] O. Chertov,et al. The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity , 2001, Cellular and Molecular Life Sciences CMLS.
[10] R. Hancock,et al. Synergistic Interactions between Mammalian Antimicrobial Defense Peptides , 2001, Antimicrobial Agents and Chemotherapy.
[11] K. Matsushima,et al. Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue. , 2001, The American journal of pathology.
[12] T. Abee,et al. Characterization of Histatin 5 with Respect to Amphipathicity, Hydrophobicity, and Effects on Cell and Mitochondrial Membrane Integrity Excludes a Candidacidal Mechanism of Pore Formation* , 2001, The Journal of Biological Chemistry.
[13] T. Tezuka,et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. , 2001, International immunology.
[14] Kathleen M. Smith,et al. Identification of a Novel Chemokine (CCL28), which Binds CCR10 (GPR2)* , 2000, The Journal of Biological Chemistry.
[15] J. Krijgsveld,et al. Thrombocidins, Microbicidal Proteins from Human Blood Platelets, Are C-terminal Deletion Products of CXC Chemokines* , 2000, The Journal of Biological Chemistry.
[16] G. Graham,et al. Cutting Edge: Identification of the Orphan Receptor G-Protein-Coupled Receptor 2 as CCR10, a Specific Receptor for the Chemokine ESkine1 2 , 2000, The Journal of Immunology.
[17] Weiqi Wang,et al. Cutting Edge: The Orphan Chemokine Receptor G Protein-Coupled Receptor-2 (GPR-2, CCR10) Binds the Skin-Associated Chemokine CCL27 (CTACK/ALP/ILC)1 , 2000, The Journal of Immunology.
[18] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[19] N. Copeland,et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Suzuki,et al. Molecular cloning of a novel CC chemokine, interleukin‐11 receptor α‐locus chemokine (ILC), which is located on chromosome 9p13 and a potential homologue of a CC chemokine encoded by molluscum contagiosum virus , 1999, FEBS letters.
[21] Ji Ming Wang,et al. β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .
[22] A. Grottesi,et al. Zn(2+) ions selectively induce antimicrobial salivary peptide histatin-5 to fuse negatively charged vesicles. Identification and characterization of a zinc-binding motif present in the functional domain. , 1999, Biochemistry.
[23] T. Abee,et al. The Cellular Target of Histatin 5 on Candida albicans Is the Energized Mitochondrion* , 1999, The Journal of Biological Chemistry.
[24] J. Isaacs,et al. Therapy with monoclonal antibodies. II. The contribution of Fc gamma receptor binding and the influence of C(H)1 and C(H)3 domains on in vivo effector function. , 1998, Journal of immunology.
[25] D. Taub,et al. Identification of Defensin-1, Defensin-2, and CAP37/Azurocidin as T-cell Chemoattractant Proteins Released from Interleukin-8-stimulated Neutrophils (*) , 1996, The Journal of Biological Chemistry.
[26] Tao Xu,et al. Anticandidal activity of major human salivary histatins , 1991, Infection and immunity.
[27] P. A. Raj,et al. Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity. , 1990, The Journal of biological chemistry.
[28] T. Ganz,et al. Monocyte-chemotactic activity of defensins from human neutrophils. , 1989, The Journal of clinical investigation.
[29] S. Levitz,et al. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. , 1988, The Journal of biological chemistry.
[30] C. Conner. Therapy with Monoclonal Antibodies , 1984, Drug intelligence & clinical pharmacy.
[31] H. Nomiyama,et al. Chemokines in immunity. , 2001, Advances in immunology.
[32] L. Schild,et al. Structure function relationships of ENaC and its role in sodium handling. , 2001, Advances in experimental medicine and biology.
[33] O. Gotoh,et al. Multiple sequence alignment: algorithms and applications. , 1999, Advances in biophysics.
[34] L. Bobek,et al. Human salivary histatins: promising anti-fungal therapeutic agents. , 1998, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.